Baxter International updates FY24 EPS guidance to $2.88-$2.98 and revenue to $15.1bn, citing strong demand for medical devices.
Baxter International (NYSE:BAX) updated its FY24 earnings guidance with EPS forecast of $2.88-$2.98 and revenue guidance of $15.1bn, compared to consensus estimates of $2.90 and $15.10bn. Q2 guidance is set at $0.65-$0.67 EPS. The company cites strong demand for medical devices, particularly infusion pumps and dialysis products, as a driving factor.
May 02, 2024
5 Articles